$25 Million Verdict Awarded to Former Accutane User
In yet another major verdict against the pharmaceutical company Hoffmann-La Roche, a New Jersey jury unanimously ordered the company to pay $25.16 million in damages to a former user of its Accutane drug, Andrew McCarrell, who alleged the acne medicine caused his inflammatory bowel disease. More...

New Study Links Isotretinoin (Accutane) Use to Ulcerative Colitis and Inflammatory Bowel Disease
An article entitled "Isotretinoin Use and the Risk of Inflammatory Bowel Disease: A Case - Control Study" recently published in The American Journal of Gastroenterology concludes that Ulcerative Colitis (UC) and Inflammatory Bowel Disease (IBD) are associated with previous isotretinoin (Accutane, Amnesteem, Sotret, Claravis) exposure. More...

Roche Pulls Accutane Off Market After Jury Verdicts
Roche Holding AG, the world's biggest maker of cancer drugs, is pulling its Accutane acne medicine from the U.S. market after juries awarded at least $33 million in damages to users who blamed the drug for bowel disease. More...

New Jersey Jury Awards $12.9 Million to Three Patients Whose Use of Roche Acne Medication Accutane Found to Cause Severe Bowel Illness
In another major courtroom verdict linking powerful acne medication Accutane with long-term inflammatory bowel disease (IBD), an eight-person jury in Atlantic City has found that pharmaceutical maker Hoffman-La Roche failed to provide adequate warning of the possible condition to three patients who began taking the drug as teenagers and shortly thereafter developed severe forms of IBD. More...

Third Straight Plaintiff's Verdict, and Largest to Date, in Accutane Litigation
On Tuesday, a jury in Atlantic City, NJ, ordered the pharmaceutical manufacturer Roche to pay plaintiff Kamie Kendall $10,578,500.00, for injuries caused by its drug Accutane.More...

Florida jury awards $7 million in Accutane case
After two days of deliberating, the jury on Thursday found Accutane maker Hoffman-La Roche Inc. responsible for failing to warn Adam Mason, 31, that he could develop inflammatory bowel disease.more....

U.S. jury awards $2.5 million in Roche Accutane trial
A New Jersey jury found that Swiss drugmaker Roche Holding AG failed to adequately warn a patient of the bowel disease risks associated with its acne medicine Accutane and awarded him $2.5 million in damages.more....

Accutane heart, liver risks higher than expected
Accutane, the powerful acne drug already known to cause birth defects, seems to raise the risk for potential heart and liver problems more than doctors had expected, according to a new study.more....

Health Canada probes Accutane side effects
Health Canada is investigating reports of strokes and heart attacks in people taking Accutane, the controversial acne drug that causes birth defects and has been linked with psychiatric problems.more....

FDA considers extending mandatory registry deadline for acne drug Accutane
The tens of thousands of Americans who take Accutane to treat their severe acne may gain additional time to register with a program designed to limit use of the birth defect-causing drug by pregnant women.more....

Women not Following Acne Drug Guidelines
A program designed to prevent women from becoming pregnant while taking the popular acne drug, isotretinoin (Accutane) may not be effective. A new study suggests guidelines are not being consistently followed. more....

FDA announces 'iPLEDGE' program for Accutane
On August 12th the FDA announced that starting December 31, 2005, thousands of Accutane users, plus the doctors who prescribe it and stores that sell it, must enroll in a national registry that ensures they understand all the drug’s risks, and take special steps to avoid the most notorious one, Accutane-damaged pregnancies. more...